Fundraising Fox
Kalaris Therapeutics, Inc.
NASDAQ: KLRSUnicorn · $1.1BBerkeley Heights, US · 3 known investors
Find your way into Kalaris Therapeutics, Inc.
Sign up to see every warm intro you have to Kalaris Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kalaris Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing treatments for prevalent retinal diseases such as wet AMD, diabetic eye disease, and retinal vein occlusion. Its lead asset is an engineered dual-targeting biologic aimed at longer-lasting anti-VEGF activity to reduce the frequency of injections for patients.
Founders & leadership
Investors · 3
How we know: Samsara BioCapital's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountprivate placementDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Kalaris Therapeutics, Inc. do?
- Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing treatments for prevalent retinal diseases such as wet AMD, diabetic eye disease, and retinal vein occlusion. Its lead asset is an engineered dual-targeting biologic aimed at longer-lasting anti-VEGF activity to reduce the frequency of injections for patients.
- Who founded Kalaris Therapeutics, Inc.?
- Kalaris Therapeutics, Inc. was founded by Srinivas Akkaraju, Mike Dybbs, Napoleone Ferrara.
- Who are Kalaris Therapeutics, Inc.'s investors?
- Kalaris Therapeutics, Inc.'s investors include Samsara BioCapital, Invus, RTW Investments L.P..
- Where is Kalaris Therapeutics, Inc. headquartered?
- Kalaris Therapeutics, Inc. is headquartered in Berkeley Heights, US.